Alkermes plc is a biopharmaceutical company based in Dublin, Ireland, focusing on developing treatments for critical unmet medical needs. It specializes in creating innovative therapies for alcohol and opioid dependence, schizophrenia, bipolar I disorder, and other neurological disorders. Its product lineup includes ARISTADA and VIVITROL, among others, aimed at improving patient outcomes. Alkermes also collaborates with leading pharmaceutical companies and leverages proprietary technology platforms to advance its research and development efforts, making significant contributions to the field of medicine since its establishment in 1987.
Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week, with the Federal 4th of July holiday scheduled for Friday, before we celebrate the 250th…
The GLP-1 revolution has reshaped biopharma M&A strategy. With Novo Nordisk and Eli Lilly generating tens of billions in annual obesity drug revenue, large-cap acquirers are scouring the biotech landscape for the…
Pre-Market Stock Futures: Futures are trading higher this morning after a dreadful day to start the trading week. Various reasons were cited for the risk-off bias on Monday, but the tariff situation,…
Wednesday's top analyst upgrades and downgrades included Ally Financial, Applied Materials, CrowdStrike, Fidelity National Information Services, First Solar, Fortinet, Newmont, Occidental Petroleum, Palo Alto Networks, Take-Two Interactive Software, Trade Desk, Twilio and…
Thursday's additional analyst upgrades and downgrades were on Alkermes, Altice USA, Fisker, Freshpet, Lincoln National, Maravai LifeSciences and more.
Friday’s additional top analyst upgrades and downgrades were on Alkermes, AppLovin, Delta Air Lines, Micron Technology, Stanley Black & Decker and more.
Wednesday’s top analyst upgrades and downgrades included Apple, Carvana, Elanco Animal Health, Gilead Sciences, Home Depot, Park Hotels & Resorts, Shoals Technologies, SNDL, SITE Centers and UDR.
Friday’s additional top analyst upgrades and downgrades included Alkermes, Callaway Golf, Canadian National Railway, Electronic Arts, Kroger and Union Pacific.
Thursday's top analyst upgrades and downgrades included Bed Bath & Beyond, Block, Citizens Financial, DoorDash, Exelon, Exxon Mobil, Halliburton, Kinross Gold, Lockheed Martin, Matador Resources, Mosaic, PagSeguro Digital, Peloton Interactive, Pinterest, Southwestern…
Thursday afternoon's top analyst upgrades and downgrades included Equifax, Corning, Iridium Communications, KB Home and Tesla.
Wednesday’s top analyst upgrades and downgrades included Beyond Meat, Capital One, Decker's Outdoors, Diageo, DoorDash, Foot Locker, Krispy Kreme, MP Materials, Redbox Entertainment, Shift4 Payments, Tronox, and Urban Outfitters.
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Thursday’s top analyst upgrades and downgrades included Advanced Micro Devices, Alkermes, Clover Health, Okta, Peloton Interactive, Starbucks and Unilever.
Thursday's top analyst upgrades and downgrades included Alkermes, Amazon.com, Citigroup, eBay, Fastly, Groupon, Lyft, Netflix, ONEOK, Roku, Uber Technologies and Zoom Video Communications.
Friday's top analyst upgrades, downgrades and initiations included Alkermes, Aurora Cannabis, BlackRock, Duke Energy, Nvidia, Ralph Lauren, SunPower, Veeva Systems and Yelp.
